Notes: GSK1482160 is an antagonist of the purinergic P2X7 receptor (IC50 = 3.2 nM for the human receptor).{67933} It inhibits increases in the levels of reactive oxygen species (ROS) induced by LPS and BzATP (Item No. 15577) in THP-1 macrophages when used at a concentration of 1 µM.{67934} GSK1482160 (20 mg/kg twice per day) decreases the accumulation of misfolded tau aggregates in the brain and improves learning and memory in the Y-maze and contextual fear conditioning tests in human P301S tau transgenic mice.{67935} It reverses mechanical allodynia in a rat model of chronic constriction injury-induced allodynia when administered at a dose of 20 mg/kg.{67933}